INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Assenagon Asset Management S.A.'s Holding History (CIK: 0001546007)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 146,082 Value ($000) $12,201 Avg Close Range
Q3 2024
Shares 232,933 Value ($000) $17,044 Avg Close Range
Q2 2024
Shares 342,843 Value ($000) $23,481 Avg Close Range
Q1 2024
Shares 649,817 Value ($000) $44,967 Avg Close Range
Q4 2023
Shares 763,974 Value ($000) $54,716 Avg Close Range
Q3 2023
Shares 488,606 Value ($000) $25,451 Avg Close Range
Q2 2023
Shares 190,303 Value ($000) $12,050 Avg Close Range
Q1 2023
Shares 132,811 Value ($000) $7,192 Avg Close Range
Q4 2022
Shares 80,228 Value ($000) $4 Avg Close Range
Q3 2022
Shares 47,422 Value ($000) $2,207 Avg Close Range
Q2 2022
Shares 39,190 Value ($000) $2,237 Avg Close Range
Q1 2022
Shares 92,700 Value ($000) $5,672 Avg Close Range
Q4 2021
Shares 128,111 Value ($000) $6,705 Avg Close Range
Q1 2021
Shares 208,301 Value ($000) $7,068 Avg Close Range
Q4 2020
Shares 203,988 Value ($000) $6,487 Avg Close Range
Q3 2020
Shares 475,894 Value ($000) $12,211 Avg Close Range
Q2 2020
Shares 266,751 Value ($000) $6,847 Avg Close Range
Q1 2020
Shares 146,139 Value ($000) $2,246 Avg Close Range
Q4 2019
Shares 18,945 Value ($000) $650 Avg Close Range